MiNK Therapeutics INKT
NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Notes Payables (2021 - 2025)

Updated

MiNK Therapeutics (INKT) recorded Notes Payables of $5.18 million in Q4 2025, down 9.5% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Notes Payables (2021 - 2025) Analysis & Trends

Starting with Q3 2021, MiNK Therapeutics' Notes Payables history includes 5 quarters.

  • Quarterly Notes Payables has ranged from $5.12 million in Q1 2025 to $65.42 million in Q3 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $5.73 million (Q3 2025), $5.51 million (Q2 2025) and $5.12 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 MiNK Therapeutics 51.69 Mn 10.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.18 Mn
Sep 30, 2025 5.73 Mn
Jun 30, 2025 5.51 Mn
Mar 31, 2025 5.12 Mn
Sep 30, 2021 65.42 Mn
API Access

MiNK Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=INKT&period=max&api_key=YOUR_API_KEY